| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 380.60 | 41.8% | 0.3% |
| Total Income | 395.80 | 39.9% | 2.6% |
| Expenditure | 367.04 | 41.4% | 0.4% |
| PBT | 28.76 | 9.5% | 42.5% |
| Net Profit | 21.36 | 21.6% | 52.6% |
| OPM | 8.90% | 1.95pp | 1.25pp |
| NPM | 5.40% | 1.26pp | 1.77pp |
| EPS | 0.69 | 12.7% | 53.3% |
Mukka Proteins FY26 Revenue Up 44% YoY to ₹1,449.5 Cr
16 May 2026 · 16 May, 8:01 pm
Summary
Mukka Proteins Limited reported a strong financial performance for the Quarter and Year ended March 31, 2026, driven by robust demand and disciplined operational execution. For FY26, revenue from operations surged by 44.0% year-over-year to ₹1,449.5 crore, with Profit After Tax (PAT) growing 18.7% to ₹57.1 crore. The fourth quarter of FY26 also demonstrated significant growth, with PAT increasing 52.6% year-over-year to ₹21.4 crore and EBITDA margin improving by 421 basis points to 12.9%. CEO & MD Mr. Kalandan Mohammed Haris highlighted the company's strategic initiatives, including international capacity expansion in Oman and Sri Lanka, and new waste management contracts, positioning Mukka Proteins for consistent growth and long-term value.
Key Highlights
- 1
Revenue from operations for FY26 increased significantly by 44.0% year-over-year, reaching ₹1,449.5 crore.
- 2
Profit After Tax (PAT) for FY26 grew by 18.7% year-over-year to ₹57.1 crore, with a PAT Margin of 3.9%.
- 3
Q4 FY26 saw a robust 52.6% year-over-year growth in Profit After Tax (PAT) to ₹21.4 crore, and the PAT margin improved by 194 basis points to 5.6%.
- 4
EBITDA for FY26 amounted to ₹145.3 crores, reflecting a 30.9% growth year-over-year, while the EBITDA margin for the quarter (Q4 FY26) improved by 421 basis points year-over-year to 12.9%.
- 5
The company received confirmation for alignment with the globally recognized MarinTrust Improver Programme, strengthening its commitment to sustainable sourcing.
- 6
Mukka Proteins is strategically expanding its international capacity with an upcoming facility in Oman and has approved investment for a new entity in Sri Lanka to enhance its global footprint.
- 7
A contract from BBMP/BSWML was secured for integrated animal waste management, reinforcing Mukka Proteins' presence in sustainable waste management and rendering operations.
Management Comments
Kalandan Mohammed Haris
FY26 has been a year of strong and resilient growth for the Company, with revenue increasing by 44% YoY to ₹1,449.5 crore, supported by robust demand and disciplined execution. EBITDA and PAT growth of 30.9% and 18.7% respectively reflect our continued focus on operational efficiency and profitability. In Q4 FY26, we sustained strong momentum, delivering significant improvements in margins and earnings on a YoY basis. Our strategic initiatives, including the Oman capacity expansion, expansion into Sri Lanka, and investment in the MPL FC HRC JV, position us well to scale operations and strengthen our global footprint. With favourable industry dynamics and continued focus on cost optimization and sustainable sourcing, we remain confident of delivering consistent growth and long-term value.
Informational and educational content only. Not investment advice.